scholarly journals Liver X Receptor Regulates Arachidonic Acid Distribution and Eicosanoid Release in Human Macrophages

2013 ◽  
Vol 33 (6) ◽  
pp. 1171-1179 ◽  
Author(s):  
Minako Ishibashi ◽  
Alexis Varin ◽  
Rodolphe Filomenko ◽  
Tatiana Lopez ◽  
Anne Athias ◽  
...  
BMC Genomics ◽  
2012 ◽  
Vol 13 (1) ◽  
pp. 50 ◽  
Author(s):  
Petri Pehkonen ◽  
Lynn Welter-Stahl ◽  
Janine Diwo ◽  
Jussi Ryynänen ◽  
Anke Wienecke-Baldacchino ◽  
...  

1992 ◽  
Vol 1 (4) ◽  
pp. 255-261
Author(s):  
Mark J. Post ◽  
Jan Dirk te Biesebeek ◽  
Johan Wemer ◽  
Hans H. van Rooij ◽  
Freek J. Zijlstra ◽  
...  

In this study the question was addressed whether cAMP mediated drugs induce a differential reduction of branches of the arachidonic acid metabolism rather than a global reduction of eicosanoid synthesis. The isolated lungs of actively sensitized rats were employed to study prostaglandin and leukotriene release in the presence and absence of the cAMP mediated drugs theophylline, milrinone, sulmazole, isobutyl-methylxanthine and salbutamol. The release of eicosanoids as measured by RIA was predominantly basal and continuous, with a mild antigen induced stimulation only for TXB2and the leukotrienes. All drugs reduced eicosanoid release globally. It is concluded that cAMP mediated drugs interfere with arachidonic acid metabolism at a site proximal to the branching into lipoxygenase and cyclo-oxygenase pathways.


1992 ◽  
Vol 263 (4) ◽  
pp. L454-L459
Author(s):  
W. E. Holden ◽  
E. M. Burnham ◽  
M. A. Lee ◽  
S. P. Bagby

Eicosanoid products of arachidonic acid are suspected modulators of hypoxic vasoconstriction in the pulmonary vasculature. Vascular endothelial cells (EC) release several eicosanoids, but there is disagreement regarding the effect of hypoxia on EC eicosanoid release. We postulated that the oxygen level of growth in culture might influence the release of eicosanoids during acute hypoxia. We studied EC cultured from the main pulmonary arteries of pigs and grown at either 5% or near 20% oxygen, representing the normal limits of oxygen exposure to endothelium in normal lungs. Although cultures grown in 5% oxygen grew slightly faster by 4 days, the confluent cell number, protein content, and baseline eicosanoid release were no different compared with paired cultures grown in 20% oxygen. However, with an acute decrease in oxygen level, cultures grown in 5% oxygen released less prostaglandin E2, F2 alpha, and 6-ketoprostaglandin F1 alpha compared with amounts released at the growth oxygen level. In contrast, cultures grown in 20% oxygen released increased amounts of these eicosanoids compared with release at the growth oxygen level. Release of thromboxane B2 was not significantly different during hypoxia between cultures grown at 5% vs. 20% oxygen. In other experiments, cyclooxygenase activity, stimulated arachidonic acid release by calcium ionophore A23187, and uptake of arachidonic acid were no different in cultures grown at 5% vs. 20% oxygen. However, arachidonic acid release during hypoxia was reduced in 5% cultures and increased in 20% cultures.(ABSTRACT TRUNCATED AT 250 WORDS)


1993 ◽  
Vol 264 (3) ◽  
pp. H973-H982 ◽  
Author(s):  
M. C. Linssen ◽  
W. Engels ◽  
P. J. Lemmens ◽  
V. V. Heijnen ◽  
M. Van Bilsen ◽  
...  

Cells were incubated in the presence of the Ca2+ ionophore A23187 (10 microM) and arachidonic acid (AA, 80 microM). The release of eicosanoids from subcultivated cardiac endothelial and fibroblast-like cells amounted to 23.3 +/- 4.5 and 2.0 +/- 0.4 nmol/mg cellular protein per 30 min, respectively. The release from isolated cardiomyocytes remained below the detection limit of the high-performance liquid chromatography assay (< 0.00015 nmol/assay). When a very sensitive radioimmunoassay was applied, cardiomyocytes released 0.002 +/- 0.0001 nmol prostacyclin per milligram cellular protein per 30 min. Prostaglandin (PG) E2 and PGF2 alpha, 12-hydroxyheptadecatrienoic acid, 11- and 15-hydroxyeicosatetraenoic acid, and thromboxane B2 were the main eicosanoids released by endothelial cells. The stable product of prostacyclin, 6-keto-PGF1 alpha, contributed relatively little to the total amount of eicosanoids formed by endothelial cells. Fibroblast-like cells released predominantly PGE2 and 6-keto-PGF1 alpha and, to a lesser extent, 12-hydroxyheptadecatrienoic and 15-hydroxyeicosatetraenoic acids. Neither endothelial cells nor fibroblast-like cells released leukotrienes. A23187 stimulated eicosanoid release from endothelial cells when exogenous AA was below 40 microM. Addition of albumin reduced the amount of eicosanoids produced. Histamine and bradykinin did not influence 6-keto-PGF1 alpha and PGE2 production in cardiomyocytes. Histamine only gave rise to a slight but significantly higher release of 6-keto-PGF1 alpha in endothelial cells.


2001 ◽  
Vol 276 (47) ◽  
pp. 43509-43515 ◽  
Author(s):  
Karl D. Whitney ◽  
Michael A. Watson ◽  
Bryan Goodwin ◽  
Cristin M. Galardi ◽  
Jodi M. Maglich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document